Uncategorized
Imprimis reports $5 million net loss in first quarter
Imprimis Pharmaceuticals reported a net loss of $5 million, or $0.26 per common share, in the first quarter of 2017 compared with a net loss of $4.5 million, or $0.43 per common share, in the same quarter of 2016. Total revenue for the quarter was $6.1 million, an increase of 39% from 2016’s first quarter of $4.4 million, according to a company press release.